ELVN 8-K 2026-10-14

Enliven Therapeutics, Inc. (ELVN) 8-K dated 2026-10-14 — accession 0001193125-26-421761. This URL is the filing, not the ELVN hub.

Enliven Therapeutics, Inc. (ELVN) is a biotechnology company listed on US.

Enliven Therapeutics, Inc. filed a 8-K on 2026-10-14. Accession 0001193125-26-421761.

Cached items: 5.02, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Income-statement cache for ELVN is thin on this filing URL. We will not invent exhibit numbers.

Not investment advice. The ELVN SEC hub lists recent forms. The stock page is the research view.